Literature DB >> 11709612

Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies.

C M Artlett1, F W Miller, L G Rider.   

Abstract

OBJECTIVE: Fetal cells have been demonstrated in the active lesions of adult women with systemic sclerosis. Because the juvenile idiopathic inflammatory myopathies (JIIM) share clinical and histopathological features with systemic sclerosis and graft-vs-host disease, we explored the possibility that maternal cells persist and play a role in the pathogenesis of JIIM.
METHODS: DNA samples extracted from peripheral blood of 28 JIIM patients (14 females, 14 males) and 23 healthy controls were assessed for microchimerism by the HLA Cw polymerase chain reaction method. HLA Cw alleles from eight mothers and three healthy siblings of JIIM patients were also examined.
RESULTS: A microchimeric allele was identified in 19 of 26 JIIM patients whose data were able to be interpreted, compared with two of 21 healthy controls (P<0.001). Subjects with microchimerism ranged in age from 4 to 28 yr. In eight cases in which maternal peripheral blood was available, the additional Cw allele present in the patients was confirmed to be identical to a maternal allele. Three healthy siblings of JIIM patients did not have evidence of a microchimeric Cw allele.
CONCLUSION: Maternal cells can persist in the peripheral blood of their children up to three decades after birth, and are found in a higher proportion in JIIM patients compared with controls. These findings, with other data, suggest that maternal cells may be involved in the immunopathogenesis of JIIM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709612     DOI: 10.1093/rheumatology/40.11.1279

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

1.  Can maternal microchimeric cells influence the fetal response toward self antigens?

Authors:  Lucie Leveque; Kiarash Khosrotehrani
Journal:  Chimerism       Date:  2011-07-01

Review 2.  Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells.

Authors:  Sau Nguyen Huu; Gil Dubernard; Selim Aractingi; Kiarash Khosrotehrani
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

3.  Microchimerism: covert genetics?

Authors:  Yi Ye; Van Zyl Berendine; Charlotte Hellmich; Kathleen M Gillespie
Journal:  Int J Mol Epidemiol Genet       Date:  2010-09-11

4.  Long term prognosis of children born to lupus patients.

Authors:  A Murashima; T Fukazawa; M Hirashima; Y Takasaki; M Oonishi; S Niijima; Y Yamashiro; A Yamataka; T Miyano; H Hashimoto
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

Review 5.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 6.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 7.  Microchimerism in children with rheumatic disorders: what does it mean?

Authors:  Ann M Reed
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

8.  Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data.

Authors:  M Mosca; M Curcio; S Lapi; G Valentini; S D'Angelo; G Rizzo; S Bombardieri
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 9.  Chimerism in myositis.

Authors:  Ann M Reed
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

Review 10.  Inherited nongenetic influences on the gut microbiome and immune system.

Authors:  Kathryn A Knoop; Lori R Holtz; Rodney D Newberry
Journal:  Birth Defects Res       Date:  2018-12-01       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.